This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale Universitys Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.
AdvaMed has released a series of state-level policy positions aimed at improving health outcomes. Called the "Patients First Agenda," the documents include state legislation and health policies that would eliminate steep out-of-pocket costs for physician-recommended breast cancer screening and diagnostics, remove cost-sharing for supplemental lung cancer imaging and diagnostics, increase coverage of biomarker testing, ensure opioid testing in emergency settings, provide Medicaid coverage of seiz
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.
Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.
tim.hodson Wed, 01/29/2025 - 12:02 Jan. 28, 2025 GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of VolusonExpert Series ultrasound systems. Voluson Expert 22, 20 and 18 combine high resolution image quality with advanced ultrasound technology and an ergonomic design for efficient workflow and a world-class user experience.
The University of Pennsylvania in Philadelphia has aimed to tackle this conundrum, developing a deep learning-based image analysis tool and AI orchestrator.
Ferumoxytol-enhanced MR angiography (MRA) appears to be safe for chronic kidney disease (CKD) patients, researchers have reported. The findings suggest a promising alternative MRA contrast agent for patients with CKD, who are vulnerable to nephrotoxicity, wrote a team led by Perry Hampilos, MD, of Massachusetts General Hospital in Boston. The group's results were published January 27 in the International Journal of Cardiovascular Imaging.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
When it comes to diagnosing and treating strokes, time is brain. Strokes are among the leading causes of death and disability worldwide, and prompt recognition is critical to improving patient outcomes. But what happens when a stroke isnt the primary concern? Incidental stroke findings strokes identified while imaging for unrelated reasons represent a unique challenge and opportunity for healthcare professionals.
Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors.
Bedford, MA-based liquid embolics developer Instylla has received clearance from the U.S. Food and Drug Administration (FDA) for its Tembo embolic system. Tembo is a bioresorbable embolization agent made of irregularly shaped, dry gelatin particles in a size range of 85 to 255 microns. The particles are designed for the embolization of hypervascular tumors and blood vessels to stop blood flow in the peripheral vasculature, the company said.
tim.hodson Wed, 01/29/2025 - 11:07 Jan. 28, 2025 Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the TemboEmbolic System. The Tembo Embolic System is a bioresorbable 1 embolization agent comprised of irregularly shaped, dry gelatin particles of a size range from 85-255m 1.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
San Francisco, CA-based radiology workflow software developer Sirona Medical has named Ken Kaufman as its new CEO. Kaufman is a seasoned executive in radiology and health information technology, the company said, with previous leadership roles at McKesson, Allscripts, IDX System Corporation, and A-Life Medical, among other firms. Sirona noted that in 2010, Kaufman co-founded PureWellness, a cloud-native population health software company.
Upgrade to 3D mammography for better accuracy, lower X-ray dosage, and increased patient demand. Learn how to transition from 2D to 3D with refurbished.
ChatGPT-4 is an effective way to extract recommendations for additional imaging (RAIs) in radiology reports, according to a study published January 29 in the American Journal of Roentgenology. The findings suggest that use of the tool could "facilitate tracking and timely completion of clinically necessary recommendations for additional imaging and thereby potentially reduce diagnostic delays," wrote a team led by Kathryn Li of Brigham and Women's Hospital and Harvard Medical School, both in Bos
For patients with newly diagnosed obstructive coronary artery disease (CAD), a multimodal machine learning model offered an 86 percent AUC for predicting MACE, which was 10 percent higher than CCTA alone and over 35 percent higher than the Framingham Risk Score.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The purpose of this study was to compare key hospitalization outcomes and cost between percutaneous ablation and external beam radiation therapy (EBRT) among patients admitted with acute cancer-related pain.
For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.
Designed for advanced OB-GYN applications, the Samsung Z20 ultrasound platform reportedly provides a combination of artificial intelligence (AI) tools and enhanced ergonomics.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
In honor of National IV Nurse Day on January 25, we spotlight the dedication and skill of our nurses who ensure patients receive the highest quality IV care. Meet five exceptional nurses who go above and beyond to provide comfort and support to patients during this critical procedure.
A new AI model can predict the effects of surgery to remove brain tumors on cognitive tasks by using neural connection data extracted from a patients pre-surgery MRI scans.
Tendon and ligament injuries can be challenging to treat due to their limited blood supply and slow healing process. Extracorporeal Magnetotransduction Therapy, or EMTT, offers an advanced, non-invasive solution that promotes healing at the cellular level.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content